MMA Guidance
For Release:
May 10, 2011
FTC Staff Finds Sanofi-Aventis, Watson Pharmaceuticals, and Synthon Holding B.V. Failed to Report Drug Patent Agreements as Required by Law
The FTC Does Not Take Enforcement Action, but Urges Industry to Closely Consider Advisory
Letter
to Helene D. Jaffe, Counsel for Sanofi-Aventis
Letter
to Joseph J. Simons and E. Anthony Figg, Counsel for Synthon Holding B.V.
Letter
to Steven C. Sunshine, Counsel for Watson Pharmaceuticals/Watson Laboratories
Last Updated:
Wednesday, April 10, 2013 9:00 AM
About Us
|
Contact Us
|
Jobs
|
No FEAR Act Data
|
Performance and Accountability Report
|
FOIA
|
Site Map
Website Policies
|
Accessibility
|
Privacy Policy
|
Browser Plug-ins
|
Related Sites
|
USA.gov
|
For FTC Staff
Federal Trade Commission, 600 Pennsylvania Avenue, N.W., Washington, D.C. 20580